structural MRI drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (11)
Papers in which this entity is mentioned.
- Tumor-informed deep sequencing of ctDNA detects minimal residual disease and predicts relapse in osteosarcoma. (2024)
- Consortium Profile: The Methylation, Imaging and NeuroDevelopment (MIND) Consortium. (2024)
- Association of Maternal and Child Anemia With Brain Structure in Early Life in South Africa. (2022)
- Hippocampal subfield abnormalities and memory functioning in children with fetal alcohol Spectrum disorders. (2021)
- Neuroimaging young children and associations with neurocognitive development in a South African birth cohort study. (2020)
- Puberty and structural brain development in humans. (2017)
- Maternal choline supplementation in a sheep model of first trimester binge alcohol fails to protect against brain volume reductions in peripubertal lambs. (2016)
- Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models. (2015)
- Magnetic resonance-based imaging in animal models of fetal alcohol spectrum disorder. (2011)
- Focus on: magnetic resonance-based studies of fetal alcohol spectrum disorders in animal models. (2011)
- Cleft lip and palate results from Hedgehog signaling antagonism in the mouse: Phenotypic characterization and clinical implications. (2010)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| mri | drug | 69 | 84 |
| structural mri | drug | 16 | 18 |
| structural magnetic resonance imaging | drug | 4 | 4 |